Bank of America
ACHN

Bank of America’s Achillion Pharmaceuticals ACHN Stock Holding History

Bank of America’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,900
Closed -$158K – 7777
2014
Q4 		$158K Sell
12,900
-21,200
-62% -$259K ﹤0.01% 5550
2014
Q3 		$340K Buy
34,100
+13,500
+66% +$125K ﹤0.01% 4927
2014
Q2 		$156K Buy
20,600
+20,200
+5,050% +$80.6K ﹤0.01% 5769
2014
Q1 		$1K Sell
400
-14,600
-97% -$51.1K ﹤0.01% 7672
2013
Q4 		$50K Sell
15,000
-14,800
-50% -$42.9K ﹤0.01% 6555
2013
Q3 		$90K Buy
+29,800
New +$204K ﹤0.01% 6057

Bank of America's ACHN Position: Q1 2020 in Review

Bank of America sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 197,794 shares — an estimated $1.19M sold.

Bank of America first reported a position in ACHN in Q2 2013 and held it in 27 quarters. The position peaked at $8.47M in Q2 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Bank of America reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Bank of America sold 197,794 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.19M.
  • Bank of America first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
  • Bank of America's Achillion Pharmaceuticals position peaked at $8.47M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.